Liliya V. Cheskidova

Liliya V. Cheskidova

Auto-generated profile, based on publicly available information

Liliya V. Cheskidova

All-Russian Research Veterinary Institute of Pathology, Pharmacology and Therapy

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Sel'skokhozyaistvennaya Biologiya
Verified
Journal Article
Closed access
SSS.V. Shabunin
S.V. Shabunin
ASA.G. Shakhov
A.G. Shakhov
GVG.A. Vostroilova
G.A. Vostroilova
LCL.V. Cheskidova
L.V. Cheskidova
PPP.A. Parshin
P.A. Parshin
NGN.A. Grigoryeva
N.A. Grigoryeva

1 August 2018 in Sel'skokhozyaistvennaya Biologiya
Verified
Journal Article
Closed access
СШС.в. Шабунин
С.в. Шабунин
ФПФармакологии И Терапии Россельхозакадемии Гну Всероссийский Научно-Исследовательский Ветеринарный Институт Патологии
Фармакологии И Терапии Россельхозакадемии Гну Всероссийский Научно-Исследовательский Ветеринарный Институт Патологии
АША.г. Шахов
А.г. Шахов
ГВГ.а. Востроилова
Г.а. Востроилова
ЛЧЛ.в. Ческидова
Л.в. Ческидова
НГН.а. Григорьева
Н.а. Григорьева

26 January 2024 in Legal regulation in veterinary medicine
Verified
Journal Article
Open access
PDF file
APA. R. Peregonchiy
A. R. Peregonchiy
LCL. V. Cheskidova
L. V. Cheskidova
IBI. V. Bryukhova
I. V. Bryukhova
OPO. B. Pavlenko
O. B. Pavlenko
The design of drugs that allow the unlimited use of animal products is an important area of veterinary pharmacology. In this regard, in the production of a new complex ointment intended for treating the skin of the udder of cows, natural components were selected. The formula for “Uberosept” ointment includes ichthyol, pine resin and camphor. One of the important stages of preclinical study of new drugs is to identify their toxic properties and evaluate their efficacy. Therefore, the purpose of our work was to determine the toxicity class and study the wound-healing effect of “Uberosept”. The acute toxicity of “Uberosept” ointment was tested during intragastric administration using a fixed dose method (GOST 32296-2013) on female white mice. The wound healing effect was studied in a full-thickness skin wound model in female rats. It has been established that “Uberosept” ointment can be classified as hazard class 5. When administered intragastrically at a maximum dose of 5000 mg/kg during the first 30 minutes and the next 14 days, no signs of intoxication were detected in all experimental mice.

1 January 2021 in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
Verified
Journal Article
Closed access
VZV.I. Zimnikov
V.I. Zimnikov
NKN.т. Klimov
N.т. Klimov
OPO.B. Pavlenko
O.B. Pavlenko
LCL.V. Cheskidova
L.V. Cheskidova
ТEТ.G. Ermolova
Т.G. Ermolova
The disease of cows with clinically pronounced catarrhal mastitis is acompanied by an intensification of the pro-cesses of lipid peroxidation and a high level of endogenous intoxication. Etiotropic therapy using the drug Synulox LC contributed to an increase in the activity of the antioxidant defense system, a decrease in the level of oxidative stress and endogenous intoxication. The most pronounced changes in the pro- and antioxidant status were noted when the antimi-crobial drug Sinulox LC and the drug “AMSF” were used together. The additional inclusion of the drug “AMSF” in the treatment regimen provided a decrease in the content of malondialdehyde in the blood by 36.3%, medium-weight molecules – by 34.2% (Р<0,0001), medium molecular peptides – by 37.4% (Р<0.0001) and endogenous intoxication index – by 27.7% (Р<0.01), an increase in vitamin А concentration – by 37.4% (Р<0.005), vitamin Е – by 27.9% (Р<0,005) and vitamin С – by 38.0% (Р<0.05), catalase activity – by 42.9% (Р<0.01) and glutathione peroxidase activity – by 37.4% (Р<0.01.) This was clinically confirmed by an increase in therapeutic efficacy.

19 August 2026 in International Journal of Veterinary Medicine
Verified
Journal Article
Open access
PDF file
VSV. A. Shutikov
V. A. Shutikov
DGD. V. Gunkin
D. V. Gunkin
DRD. E. Rud
D. E. Rud
EMEvgeniy Mikhaylov
Evgeniy Mikhaylov
LCL. V. Chеskidova
L. V. Chеskidova
The article presents an assessment of the effect of complex therapy of respiratory pathology on the expression of IFNAR1, IKBKB genes and indicators of cellular immunity in 3-month-old calves. Threegroups were formed for the experiment: healthy animals (n=10) – group I; sick calves treated with «Azitronit» and «Butophan» (n=10) — group II; sick calves treated with «Azitronit» and «Proautovac» (n=10) — group III. It was found that after 5 days, IFNAR1 expression in all the studied groups approached the values of healthy animals, and after 7 days it was completely suppressed. The expression of the IKBKB gene in group II calves 7 days after the start of treatment corresponded to the indicators of group I animals, and in group III calves it was 2 times lower. 5 and 7 days after the start of treatment with «Proautovac», a significant increase in the PhAL was recorded by 3,4 % and 4,3 % in calves compared with group II. The PhI and PhN in group III animals were higher than in group II by 11,3 % and 10,0 % 60 hours after the start of treatment, by 21,3 % and 28,2 % after 5 days, and by 18,1 % and 14,2 % after 7 days. 7 days after the start of treatment, the blood levels of B- and T lymphocytes in group III calves were 21,0 % and 29,2 % higher than when using «Butophan». At the end of the experiment, the indicators of cellular immunity when using «Proautovac» did not differ statistically significantly from healthy animals. Thus, the use of «Proautovac» provided faster normalization and restoration of signaling pathways and cellular mechanisms of immunity, which justifies the use of cytokine-based drugs (type I/II interferons, GM-CSF and vitamins A, E, and C) in the complex treatment of bronchopneumonia in calves.

31 March 2025 in BULLETIN OF VETERINARY PHARMACOLOGY
Verified
Journal Article
Closed access
ГВГ.а. Востроилова
Г.а. Востроилова
ВГВ.а. Грицюк
В.а. Грицюк
ЛЧЛ.в. Ческидова
Л.в. Ческидова
ВЗВ.и. Зимников
В.и. Зимников
АКА.а. Корчагина
А.а. Корчагина
В статье представлены результаты изучения эффективности схемы лечения мастита у коров, включающей применение комплексного препарата «Диомаст-КРС» и Липотона. Для проведения экспериментальных исследований было отобрано 49 коров, больных маститом, которые по принципу аналогов были распределены в 2 группы. Животным первой группы применяли Диомаст-КРС согласно инструкции, второй группе дополнительно внутримышечно вводили Липотон в дозе 0,02 мл/кг двукратно с интервалом 48 часов. Установлено, что наилучший терапевтический эффект получен при совместном применении Липотона и Диомаста-КРС, который при гнойно-катаральной форме мастита составил 92,3 %, при катаральной — 91,7 %, что выше показателей базового варианта на 7,7—9,9 %, при этом излечено 93,3 и 92,3 % долей вымени соответственно. Контаминация молока микрофлорой снизилась при введении Диомаста-КРС в 4 раза, а при дополнительном использовании Липотона — в 6 раз и при этом бактерионосительство было ниже в 1,5 раза. Терапия больных маститом коров при применении Липотона сопровождалась более ранним купированием воспалительного процесса в молочной железе, выраженной активизацией гуморального и клеточного звена естественной резистентности, интенсивным снижением процессов пероксидации липидов и активизацией ферментативного и неферментативного звена антиоксидантной защиты. The article presents the results of studying the efficacy of the therapeutic regimen for bovine mastitis, including the use of the complex drug “Diomast-KRS” and Lipoton. For experimental studies, 49 cows with mastitis were selected, which were divided into 2 groups according to the principle of analogues. The animals of the first group were given “Diomast-KRS” according to the instructions, the second group was additionally administered Lipoton intramuscularly at a dose of 0.02 ml/kg twice with an interval of 48 hours. It had been found that the best therapeutic effect was obtained with the combined use of Lipoton and “Diomast-KRS”, which was 92.3 % for purulent-catarrhal mastitis, 91.7 % — for catarrhal mastitis, which was by 7.7—9.9 % higher than the baseline values, while 93.3 and 92.3 % of the udder lobes were cured, respectively. Milk contamination with microflora decreased by 4 times with the introduction of “Diomast-KRS”, and by 6 times with the additional use of Lipoton, while the bacterial carriage was by 1.5 times lower. Therapy of cows with mastitis using Lipoton was accompanied by earlier relief of the inflammatory process in the mammary gland, pronounced activation of the humoral and cellular links of natural resistance, an intensive decrease in lipid peroxidation processes and activation of the enzymatic and non-enzymatic links of antioxidant protection.